 It was only 3 years ago that an acquired translocation of EML4 with ALK leading to the expression of an EML4-ALK oncoprotein in non-small cell lung cancer (NSCLC) was reported.     ///    "Tumor cells expressing EML4-ALK are ""addicted"" to its continued function. "